New study tests linaclotide for chronic constipation relief
Symptom relief
Not yet recruiting
This study tests two doses of linaclotide (72 mcg and 145 mcg) against a placebo in 90 adults with chronic constipation or constipation-predominant irritable bowel syndrome. Participants take the drug daily for 8 weeks and record their bowel movements and symptoms. The goal is to…
Phase: PHASE4 • Sponsor: Md Mehedi Shahriar • Aim: Symptom relief
Last updated May 20, 2026 11:54 UTC